Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-01-18FDA Approved: LACOSAMIDE — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for lacosamide submitted by XLCare Pharmaceuticals Inc., updating the product labeling under the…
-
FDA approval · 2023-01-18FDA Approved: GABAPENTIN — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's gabapentin in an Original Application, granting a generic version of gabapentin (ANDA 216492).
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam submitted by Hikma Pharmaceuticals USA Inc., marking regulatory action to support t…
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for diazepam oral solution concentrate from Chartwell RX, LLC, adding/confirming approval for this d…
-
FDA approval · 2023-01-17FDA Approved: MIDAZOLAM — Supplemental Application (Steriscience Specialties Private Limited)
FDA approved a supplemental application for Midazolam hydrochloride (Midazolam) by Steriscience Specialties Private Limited under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-01-17FDA Approved: CLONAZEPAM — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for clonazepam submitted by Par Health USA, LLC, supporting continued use of this generic benzod…
-
FDA approval · 2023-01-17FDA Approved: CLONAZEPAM — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for clonazepam, confirming approval of a generic clonazepam product.
-
FDA approval · 2023-01-13FDA Approved: VALTOCO — Supplemental Application (Neurelis, Inc)
FDA approved a supplemental application for VALTOCO (diazepam) by Neurelis, Inc.
-
FDA approval · 2023-01-13FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for ONFI (clobazam) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2023-01-13FDA Approved: NAYZILAM — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Nayzilam (midazolam) from UCB, Inc.
-
FDA approval · 2023-01-11FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for diazepam (generic) from Natco Pharma USA LLC under ANDA210363.
-
FDA approval · 2023-01-06FDA Approved: BRIVARACETAM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of brivaracetam from Aurobindo Pharma Limited under an Original Application (ANDA 214848).
-
FDA approval · 2023-01-05FDA Approved: LEVETIRACETAM — Supplemental Application (Prinston Pharmaceutical Inc.)
FDA approves a supplemental application for levetiracetam from Prinston Pharmaceutical Inc., indicating an update or expansion to the existi…
-
FDA approval · 2023-01-05FDA Approved: LEVETIRACETAM — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for levetiracetam from ScieGen Pharmaceuticals, Inc. The approval pertains to the generic product in…
-
FDA approval · 2023-01-05FDA Approved: LACOSAMIDE — Original Application (Aurobindo Pharma Limited)
FDA granted approval for lacosamide as an Original Application for Aurobindo Pharma Limited, enabling a generic lacosamide product.
-
FDA approval · 2022-12-27FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part B [Phase 2]
Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42006 in People With Focal Seizures - Part A [Phase 2]
Phase 2 trial update for GWP42006 in people with focal seizures (epilepsy) has been completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy [Phase 2]
Phase 2 clinical trial update evaluating possible drug-drug interactions between stiripentol or valproate and cannabidiol in epilepsy patien…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy [Phase 2]
Open-label extension to assess potential drug-drug interactions between stiripentol or valproate and cannabidiol in epilepsy patients (Phase…
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus [Phase 2]
Phase 2 clinical trial evaluating intravenous ganaxolone as adjunctive therapy for status epilepticus (completed; results posted).
-
FDA label_change · 2022-12-14FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for clonazepam filed by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-12-02FDA Approved: CARBAMAZEPINE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved the original application for a generic carbamazepine product from Ingenus Pharmaceuticals, LLC.
-
FDA approval · 2022-11-30FDA Approved: OXCARBAZEPINE — Original Application (EPIC PHARMA, LLC)
FDA approved a generic oxcarbazepine product from Epic Pharma through an Original Application (ANDA).
-
FDA approval · 2022-11-28FDA Approved: TOPIRAMATE — Original Application (Zydus Lifesciences Limited)
FDA approved Zydus Lifesciences Limited's Original Application for a generic Topiramate. Topiramate is used for epilepsy and migraine prophy…